NASHVILLE, Tenn. / Feb 23, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that the company and the HCA Healthcare Foundation gave a total of more than $44 million to community organizations in 2022, exceeding the $41 million given in 2021. This includes HCA Healthcare and HCA Healthcare Foundation contributions to organizations focused on disaster relief, health equity, access to healthcare careers and community needs, as well as matching gifts which support colleague charities of choice.
“Caring for the communities where our colleagues live and work, through charitable donations, strategic partnerships, board leadership and volunteering, is a top priority for HCA Healthcare,” said Joanne Pulles, vice president of community engagement at HCA Healthcare and president of the HCA Healthcare Foundation. “It is an honor to work alongside and invest in organizations who share our desire to improve lives and give our communities a healthier tomorrow.”
Throughout the year, HCA Healthcare invested in a number of initiatives to improve health equity. In October 2022, HCA Healthcare and the HCA Healthcare Foundation announced a $15 million collaboration with the American Heart Association that seeks to prevent, treat and beat stroke, partly by addressing health disparities and resource gaps through local health impact work. HCA Healthcare also strengthened its longstanding partnership with March of Dimes to improve maternal health outcomes by contributing more than $1.1 million last year. Additionally, HCA Healthcare announced a collaboration with Johnson & Johnson which will in part focus on improving lung health equity in the Black community.
HCA Healthcare is also investing in institutions which educate aspiring healthcare professionals. In January 2022, the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, committed $1.35 million over the next three years to Educate Texas, an initiative which aims to increase student access to programs that enable healthcare careers. Recently, $250,000 in Healthier Tomorrow Fund grants were given to community colleges and universities to help high school students nationwide learn about various healthcare careers.
The company has also announced approximately $6.8 million towards its $10 million commitment to supporting Historically Black Colleges and Universities (HBCUs) and Hispanic Serving Institutions (HSIs). Most recently, HCA Healthcare donated $1.5 million to Fisk University to support scholarships for students pursuing a degree in nursing and $1.5 million to Tennessee State University to create scholarship opportunities for undergraduate students pursuing careers in healthcare and computer science.
In addition to direct contributions, the company also encourages volunteering and offers matching gifts to help colleagues further support the charity of their choice. In 2022, colleague giving with HCA Healthcare matching reached nearly $17 million, and HCA Healthcare colleagues logged approximately 143,878 hours spent volunteering.
HCA Healthcare and the HCA Healthcare Foundation have a long history of supporting the Middle Tennessee community where HCA Healthcare is headquartered. In 2022, the HCA Healthcare Foundation, through its Middle Tennessee Fund, awarded $6.3 million in grants to 219 nonprofit agencies across Middle Tennessee. 80% of grants went to organizations focused on promoting health and well-being and providing primary care or basic needs to members of our communities. Other grant recipients included those focusing on education and the arts.
Additionally, HCA Healthcare and its colleagues invested in communities through the following initiatives in 2022:
In addition to contributions to community organizations, HCA Healthcare provided uncompensated care in 2022 at an estimated cost of approximately $3.5 billion.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 182 hospitals and approximately 2,300 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its more than 35 million annual patient encounters to advance science, improve patient care and save lives. Please click here to connect with HCA Healthcare on social media.
About HCA Healthcare Foundation
The mission of the HCA Healthcare Foundation is to promote health and well-being and strive to make a positive impact in all the communities HCA Healthcare serves. We accomplish this mission by providing leadership, service and financial support to effective non-profit organizations working individually and collectively.
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
Last Trade: | US$335.55 |
Daily Change: | -5.07 -1.49 |
Daily Volume: | 974,226 |
Market Cap: | US$84.990B |
February 20, 2025 February 18, 2025 October 25, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load